NewGenIvf (NIVF) Operating Income (2024 - 2025)

NewGenIvf (NIVF) posted quarterly Operating Income of -$5.0 million for Q4 2025, down 356.66% YoY from $1.9 million in Q4 2024, and down 97.95% sequentially from -$2.5 million in Q3 2025.

NewGenIvf (NIVF) Operating Income (2024 - 2025) Analysis & Trends

NewGenIvf has disclosed Operating Income across 2 years of filings, most recently posting -$5.0 million for Q4 2025.

  • In Q4 2025, Operating Income fell 356.66% year-over-year to -$5.0 million; the TTM figure through Dec 2025 stood at -$8.4 million (changed N/A YoY), while the FY2025 annual figure was -$10.7 million, down 824.3% from the prior year.
  • Operating Income declined to -$5.0 million in Q4 2025, from -$2.5 million in the prior quarter.
  • Over the last five years, Operating Income for NIVF reached as high as $216311.0 in Q3 2024 and fell as low as -$5.0 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 HCA Healthcare 87.94 Bn 90.32 Bn 16.26 Bn -566.00 Mn
2 Chemed 18.08 Bn 18.07 Bn 215.76 Mn 84.58 Mn
3 Tenet Healthcare 16.59 Bn 15.76 Bn 4.41 Bn 1.30 Bn
4 Davita 15.37 Bn 16.23 Bn 1.07 Bn 481.89 Mn
5 Encompass Health 10.07 Bn 10.70 Bn 1.34 Bn 59.70 Mn
6 Ensign 9.52 Bn 8.93 Bn 293.37 Mn 124.85 Mn
7 Universal Health Services 9.19 Bn 9.15 Bn 3.21 Bn 502.86 Mn
8 Pacs 6.96 Bn 6.72 Bn 345.96 Mn 120.04 Mn
9 Ww International 6.14 Bn 5.98 Bn -149.29 Mn -34.14 Mn
10 NewGenIvf 25,304.95 -1.41 Mn 524,025.00 -4.97 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -4.97 Mn
Sep 30, 2025 -2.51 Mn
Dec 31, 2024 -1.09 Mn
Sep 30, 2024 216,311.00